nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Docetaxel—melanoma	0.281	0.449	CbGbCtD
Tenofovir—CYP1A2—Carmustine—melanoma	0.11	0.176	CbGbCtD
Tenofovir—CYP1A2—Vemurafenib—melanoma	0.0872	0.139	CbGbCtD
Tenofovir—ABCC2—Docetaxel—melanoma	0.0803	0.128	CbGbCtD
Tenofovir—CYP1A2—Dacarbazine—melanoma	0.0669	0.107	CbGbCtD
Tenofovir—AK2—optic choroid—melanoma	0.0285	0.251	CbGeAlD
Tenofovir—SLC22A8—optic choroid—melanoma	0.00823	0.0725	CbGeAlD
Tenofovir—NME1-NME2—eye—melanoma	0.00757	0.0666	CbGeAlD
Tenofovir—NME1—neck—melanoma	0.00592	0.0521	CbGeAlD
Tenofovir—AK2—eye—melanoma	0.00574	0.0505	CbGeAlD
Tenofovir—Adenosine triphosphate—APAF1—melanoma	0.00501	0.758	CrCbGaD
Tenofovir—AK2—mammalian vulva—melanoma	0.00455	0.0401	CbGeAlD
Tenofovir—NME1-NME2—head—melanoma	0.0043	0.0378	CbGeAlD
Tenofovir—AK4—eye—melanoma	0.00424	0.0374	CbGeAlD
Tenofovir—AK4—retina—melanoma	0.0042	0.037	CbGeAlD
Tenofovir—NME2—eye—melanoma	0.00415	0.0365	CbGeAlD
Tenofovir—NME2—retina—melanoma	0.00411	0.0362	CbGeAlD
Tenofovir—NME1—skin of body—melanoma	0.00383	0.0337	CbGeAlD
Tenofovir—AK4—mammalian vulva—melanoma	0.00337	0.0296	CbGeAlD
Tenofovir—NME1-NME2—lymph node—melanoma	0.00301	0.0265	CbGeAlD
Tenofovir—NME1—head—melanoma	0.0025	0.022	CbGeAlD
Tenofovir—AK4—head—melanoma	0.00241	0.0212	CbGeAlD
Tenofovir—NME2—head—melanoma	0.00235	0.0207	CbGeAlD
Tenofovir—AK2—lymph node—melanoma	0.00228	0.0201	CbGeAlD
Tenofovir—Hepatomegaly—Dactinomycin—melanoma	0.00224	0.0195	CcSEcCtD
Tenofovir—Myopathy—Temozolomide—melanoma	0.00204	0.0178	CcSEcCtD
Tenofovir—NME1—lymph node—melanoma	0.00175	0.0154	CbGeAlD
Tenofovir—AK4—lymph node—melanoma	0.00169	0.0148	CbGeAlD
Tenofovir—SLC22A8—eye—melanoma	0.00166	0.0146	CbGeAlD
Tenofovir—NME2—lymph node—melanoma	0.00165	0.0145	CbGeAlD
Tenofovir—ABCC10—mammalian vulva—melanoma	0.0016	0.0141	CbGeAlD
Tenofovir—Weight decreased—Vemurafenib—melanoma	0.00159	0.0139	CcSEcCtD
Tenofovir—Infestation NOS—Vemurafenib—melanoma	0.00157	0.0137	CcSEcCtD
Tenofovir—Infestation—Vemurafenib—melanoma	0.00157	0.0137	CcSEcCtD
Tenofovir—Neuropathy peripheral—Vemurafenib—melanoma	0.00154	0.0134	CcSEcCtD
Tenofovir—Connective tissue disorder—Vemurafenib—melanoma	0.00138	0.0121	CcSEcCtD
Tenofovir—Adenosine triphosphate—AKT1—melanoma	0.00136	0.206	CrCbGaD
Tenofovir—Mediastinal disorder—Vemurafenib—melanoma	0.00127	0.0111	CcSEcCtD
Tenofovir—Malnutrition—Vemurafenib—melanoma	0.00123	0.0107	CcSEcCtD
Tenofovir—Back pain—Vemurafenib—melanoma	0.00119	0.0103	CcSEcCtD
Tenofovir—Myalgia—Vemurafenib—melanoma	0.00104	0.00909	CcSEcCtD
Tenofovir—Arthralgia—Vemurafenib—melanoma	0.00104	0.00909	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00104	0.00903	CcSEcCtD
Tenofovir—Bone pain—Docetaxel—melanoma	0.000994	0.00866	CcSEcCtD
Tenofovir—Nervous system disorder—Vemurafenib—melanoma	0.000981	0.00854	CcSEcCtD
Tenofovir—Hypokalaemia—Carmustine—melanoma	0.000979	0.00853	CcSEcCtD
Tenofovir—Skin disorder—Vemurafenib—melanoma	0.000971	0.00846	CcSEcCtD
Tenofovir—Weight decreased—Bleomycin—melanoma	0.000964	0.0084	CcSEcCtD
Tenofovir—Pneumonia—Bleomycin—melanoma	0.000955	0.00832	CcSEcCtD
Tenofovir—Muscular weakness—Carmustine—melanoma	0.000949	0.00827	CcSEcCtD
Tenofovir—ABCC4—head—melanoma	0.000948	0.00834	CbGeAlD
Tenofovir—Hypokalaemia—Temozolomide—melanoma	0.000946	0.00825	CcSEcCtD
Tenofovir—SLC22A8—head—melanoma	0.00094	0.00828	CbGeAlD
Tenofovir—Muscular weakness—Temozolomide—melanoma	0.000917	0.00799	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000911	0.00794	CcSEcCtD
Tenofovir—Haematuria—Bleomycin—melanoma	0.000906	0.00789	CcSEcCtD
Tenofovir—Pneumonia—Dactinomycin—melanoma	0.000891	0.00776	CcSEcCtD
Tenofovir—Decreased appetite—Vemurafenib—melanoma	0.000869	0.00757	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Vemurafenib—melanoma	0.000863	0.00752	CcSEcCtD
Tenofovir—Fatigue—Vemurafenib—melanoma	0.000862	0.00751	CcSEcCtD
Tenofovir—Hyperglycaemia—Carmustine—melanoma	0.000839	0.00731	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Temozolomide—melanoma	0.000835	0.00728	CcSEcCtD
Tenofovir—Pneumonia—Carmustine—melanoma	0.000834	0.00727	CcSEcCtD
Tenofovir—Depression—Carmustine—melanoma	0.000827	0.0072	CcSEcCtD
Tenofovir—Renal failure—Carmustine—melanoma	0.000815	0.0071	CcSEcCtD
Tenofovir—Weight decreased—Temozolomide—melanoma	0.000813	0.00708	CcSEcCtD
Tenofovir—Neuropathy peripheral—Carmustine—melanoma	0.000813	0.00708	CcSEcCtD
Tenofovir—Hyperglycaemia—Temozolomide—melanoma	0.000811	0.00706	CcSEcCtD
Tenofovir—Pneumonia—Temozolomide—melanoma	0.000806	0.00702	CcSEcCtD
Tenofovir—Infestation NOS—Temozolomide—melanoma	0.000801	0.00698	CcSEcCtD
Tenofovir—Infestation—Temozolomide—melanoma	0.000801	0.00698	CcSEcCtD
Tenofovir—ABCC10—lymph node—melanoma	0.0008	0.00704	CbGeAlD
Tenofovir—Depression—Temozolomide—melanoma	0.000799	0.00696	CcSEcCtD
Tenofovir—Hepatitis—Dactinomycin—melanoma	0.000795	0.00693	CcSEcCtD
Tenofovir—Body temperature increased—Vemurafenib—melanoma	0.00079	0.00689	CcSEcCtD
Tenofovir—Neuropathy peripheral—Temozolomide—melanoma	0.000785	0.00684	CcSEcCtD
Tenofovir—Hepatobiliary disease—Temozolomide—melanoma	0.000758	0.0066	CcSEcCtD
Tenofovir—Sinusitis—Temozolomide—melanoma	0.000752	0.00655	CcSEcCtD
Tenofovir—Hypersensitivity—Vemurafenib—melanoma	0.000737	0.00642	CcSEcCtD
Tenofovir—Connective tissue disorder—Carmustine—melanoma	0.000731	0.00637	CcSEcCtD
Tenofovir—Renal impairment—Docetaxel—melanoma	0.000727	0.00633	CcSEcCtD
Tenofovir—Hepatitis—Temozolomide—melanoma	0.000719	0.00627	CcSEcCtD
Tenofovir—Asthenia—Vemurafenib—melanoma	0.000717	0.00625	CcSEcCtD
Tenofovir—Urinary tract disorder—Temozolomide—melanoma	0.00071	0.00619	CcSEcCtD
Tenofovir—Pruritus—Vemurafenib—melanoma	0.000707	0.00616	CcSEcCtD
Tenofovir—Connective tissue disorder—Temozolomide—melanoma	0.000707	0.00616	CcSEcCtD
Tenofovir—Urethral disorder—Temozolomide—melanoma	0.000705	0.00614	CcSEcCtD
Tenofovir—Diarrhoea—Vemurafenib—melanoma	0.000684	0.00596	CcSEcCtD
Tenofovir—ABCC4—lymph node—melanoma	0.000664	0.00584	CbGeAlD
Tenofovir—Dizziness—Vemurafenib—melanoma	0.000661	0.00576	CcSEcCtD
Tenofovir—Mental disorder—Carmustine—melanoma	0.000652	0.00568	CcSEcCtD
Tenofovir—Immune system disorder—Temozolomide—melanoma	0.00065	0.00566	CcSEcCtD
Tenofovir—Mediastinal disorder—Temozolomide—melanoma	0.000648	0.00565	CcSEcCtD
Tenofovir—Malnutrition—Carmustine—melanoma	0.000648	0.00565	CcSEcCtD
Tenofovir—ABCC2—lymph node—melanoma	0.000642	0.00566	CbGeAlD
Tenofovir—Vomiting—Vemurafenib—melanoma	0.000636	0.00554	CcSEcCtD
Tenofovir—Myalgia—Bleomycin—melanoma	0.000632	0.00551	CcSEcCtD
Tenofovir—Chest pain—Bleomycin—melanoma	0.000632	0.00551	CcSEcCtD
Tenofovir—Rash—Vemurafenib—melanoma	0.00063	0.00549	CcSEcCtD
Tenofovir—Mental disorder—Temozolomide—melanoma	0.00063	0.00549	CcSEcCtD
Tenofovir—Dermatitis—Vemurafenib—melanoma	0.00063	0.00549	CcSEcCtD
Tenofovir—Back pain—Carmustine—melanoma	0.000627	0.00546	CcSEcCtD
Tenofovir—Headache—Vemurafenib—melanoma	0.000626	0.00546	CcSEcCtD
Tenofovir—Malnutrition—Temozolomide—melanoma	0.000626	0.00546	CcSEcCtD
Tenofovir—Nasopharyngitis—Docetaxel—melanoma	0.000618	0.00539	CcSEcCtD
Tenofovir—Back pain—Temozolomide—melanoma	0.000606	0.00528	CcSEcCtD
Tenofovir—Nausea—Vemurafenib—melanoma	0.000594	0.00518	CcSEcCtD
Tenofovir—Myalgia—Dactinomycin—melanoma	0.000589	0.00514	CcSEcCtD
Tenofovir—Anorexia—Bleomycin—melanoma	0.000577	0.00503	CcSEcCtD
Tenofovir—Angioedema—Temozolomide—melanoma	0.000572	0.00499	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Bleomycin—melanoma	0.000552	0.00481	CcSEcCtD
Tenofovir—Myalgia—Carmustine—melanoma	0.000552	0.00481	CcSEcCtD
Tenofovir—Chest pain—Carmustine—melanoma	0.000552	0.00481	CcSEcCtD
Tenofovir—Anxiety—Carmustine—melanoma	0.00055	0.00479	CcSEcCtD
Tenofovir—Weight decreased—Docetaxel—melanoma	0.000541	0.00471	CcSEcCtD
Tenofovir—Dyspnoea—Bleomycin—melanoma	0.00054	0.00471	CcSEcCtD
Tenofovir—Anorexia—Dactinomycin—melanoma	0.000539	0.00469	CcSEcCtD
Tenofovir—Pneumonia—Docetaxel—melanoma	0.000536	0.00467	CcSEcCtD
Tenofovir—Arthralgia—Temozolomide—melanoma	0.000533	0.00464	CcSEcCtD
Tenofovir—Myalgia—Temozolomide—melanoma	0.000533	0.00464	CcSEcCtD
Tenofovir—Infestation NOS—Docetaxel—melanoma	0.000533	0.00464	CcSEcCtD
Tenofovir—Infestation—Docetaxel—melanoma	0.000533	0.00464	CcSEcCtD
Tenofovir—Anxiety—Temozolomide—melanoma	0.000531	0.00463	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000529	0.00461	CcSEcCtD
Tenofovir—Decreased appetite—Bleomycin—melanoma	0.000527	0.00459	CcSEcCtD
Tenofovir—Renal failure—Docetaxel—melanoma	0.000524	0.00456	CcSEcCtD
Tenofovir—Neuropathy peripheral—Docetaxel—melanoma	0.000522	0.00455	CcSEcCtD
Tenofovir—Pain—Bleomycin—melanoma	0.000518	0.00451	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000515	0.00449	CcSEcCtD
Tenofovir—Anorexia—Carmustine—melanoma	0.000504	0.00439	CcSEcCtD
Tenofovir—Hepatobiliary disease—Docetaxel—melanoma	0.000504	0.00439	CcSEcCtD
Tenofovir—Nervous system disorder—Temozolomide—melanoma	0.000501	0.00437	CcSEcCtD
Tenofovir—Skin disorder—Temozolomide—melanoma	0.000496	0.00433	CcSEcCtD
Tenofovir—Hyperhidrosis—Temozolomide—melanoma	0.000494	0.0043	CcSEcCtD
Tenofovir—Decreased appetite—Dactinomycin—melanoma	0.000491	0.00428	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—melanoma	0.000487	0.00424	CcSEcCtD
Tenofovir—Anorexia—Temozolomide—melanoma	0.000487	0.00424	CcSEcCtD
Tenofovir—Pain—Dactinomycin—melanoma	0.000483	0.00421	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Carmustine—melanoma	0.000482	0.0042	CcSEcCtD
Tenofovir—Body temperature increased—Bleomycin—melanoma	0.000479	0.00417	CcSEcCtD
Tenofovir—Hepatitis—Docetaxel—melanoma	0.000478	0.00417	CcSEcCtD
Tenofovir—Insomnia—Carmustine—melanoma	0.000478	0.00417	CcSEcCtD
Tenofovir—Urinary tract disorder—Docetaxel—melanoma	0.000472	0.00412	CcSEcCtD
Tenofovir—Dyspnoea—Carmustine—melanoma	0.000471	0.00411	CcSEcCtD
Tenofovir—Connective tissue disorder—Docetaxel—melanoma	0.00047	0.0041	CcSEcCtD
Tenofovir—Urethral disorder—Docetaxel—melanoma	0.000469	0.00409	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Temozolomide—melanoma	0.000466	0.00406	CcSEcCtD
Tenofovir—Insomnia—Temozolomide—melanoma	0.000462	0.00403	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—melanoma	0.000462	0.00403	CcSEcCtD
Tenofovir—Decreased appetite—Carmustine—melanoma	0.00046	0.00401	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Carmustine—melanoma	0.000457	0.00398	CcSEcCtD
Tenofovir—Dyspnoea—Temozolomide—melanoma	0.000456	0.00397	CcSEcCtD
Tenofovir—Pain—Carmustine—melanoma	0.000452	0.00394	CcSEcCtD
Tenofovir—Dyspepsia—Temozolomide—melanoma	0.00045	0.00392	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—melanoma	0.000447	0.00389	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—melanoma	0.000447	0.00389	CcSEcCtD
Tenofovir—Hypersensitivity—Bleomycin—melanoma	0.000446	0.00389	CcSEcCtD
Tenofovir—Decreased appetite—Temozolomide—melanoma	0.000444	0.00387	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Temozolomide—melanoma	0.000441	0.00384	CcSEcCtD
Tenofovir—Fatigue—Temozolomide—melanoma	0.000441	0.00384	CcSEcCtD
Tenofovir—Pain—Temozolomide—melanoma	0.000437	0.00381	CcSEcCtD
Tenofovir—Asthenia—Bleomycin—melanoma	0.000435	0.00379	CcSEcCtD
Tenofovir—Gastrointestinal pain—Carmustine—melanoma	0.000432	0.00377	CcSEcCtD
Tenofovir—Immune system disorder—Docetaxel—melanoma	0.000432	0.00376	CcSEcCtD
Tenofovir—Mediastinal disorder—Docetaxel—melanoma	0.000431	0.00376	CcSEcCtD
Tenofovir—Pruritus—Bleomycin—melanoma	0.000429	0.00373	CcSEcCtD
Tenofovir—Mental disorder—Docetaxel—melanoma	0.000419	0.00365	CcSEcCtD
Tenofovir—Body temperature increased—Carmustine—melanoma	0.000418	0.00364	CcSEcCtD
Tenofovir—Abdominal pain—Carmustine—melanoma	0.000418	0.00364	CcSEcCtD
Tenofovir—Gastrointestinal pain—Temozolomide—melanoma	0.000418	0.00364	CcSEcCtD
Tenofovir—Malnutrition—Docetaxel—melanoma	0.000416	0.00363	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—melanoma	0.000416	0.00363	CcSEcCtD
Tenofovir—Asthenia—Dactinomycin—melanoma	0.000405	0.00353	CcSEcCtD
Tenofovir—Body temperature increased—Temozolomide—melanoma	0.000404	0.00352	CcSEcCtD
Tenofovir—Abdominal pain—Temozolomide—melanoma	0.000404	0.00352	CcSEcCtD
Tenofovir—Back pain—Docetaxel—melanoma	0.000403	0.00351	CcSEcCtD
Tenofovir—Hypersensitivity—Carmustine—melanoma	0.00039	0.00339	CcSEcCtD
Tenofovir—Diarrhoea—Dactinomycin—melanoma	0.000387	0.00337	CcSEcCtD
Tenofovir—Vomiting—Bleomycin—melanoma	0.000385	0.00336	CcSEcCtD
Tenofovir—Rash—Bleomycin—melanoma	0.000382	0.00333	CcSEcCtD
Tenofovir—Dermatitis—Bleomycin—melanoma	0.000382	0.00333	CcSEcCtD
Tenofovir—Asthenia—Carmustine—melanoma	0.000379	0.00331	CcSEcCtD
Tenofovir—Hypersensitivity—Temozolomide—melanoma	0.000376	0.00328	CcSEcCtD
Tenofovir—Asthenia—Temozolomide—melanoma	0.000367	0.00319	CcSEcCtD
Tenofovir—Diarrhoea—Carmustine—melanoma	0.000362	0.00315	CcSEcCtD
Tenofovir—Pruritus—Temozolomide—melanoma	0.000362	0.00315	CcSEcCtD
Tenofovir—Nausea—Bleomycin—melanoma	0.00036	0.00314	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—melanoma	0.000359	0.00313	CcSEcCtD
Tenofovir—Rash—Dactinomycin—melanoma	0.000356	0.0031	CcSEcCtD
Tenofovir—Chest pain—Docetaxel—melanoma	0.000354	0.00309	CcSEcCtD
Tenofovir—Myalgia—Docetaxel—melanoma	0.000354	0.00309	CcSEcCtD
Tenofovir—Arthralgia—Docetaxel—melanoma	0.000354	0.00309	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000352	0.00307	CcSEcCtD
Tenofovir—Dizziness—Carmustine—melanoma	0.00035	0.00305	CcSEcCtD
Tenofovir—Diarrhoea—Temozolomide—melanoma	0.00035	0.00305	CcSEcCtD
Tenofovir—Dizziness—Temozolomide—melanoma	0.000338	0.00294	CcSEcCtD
Tenofovir—Vomiting—Carmustine—melanoma	0.000336	0.00293	CcSEcCtD
Tenofovir—Nausea—Dactinomycin—melanoma	0.000336	0.00292	CcSEcCtD
Tenofovir—Rash—Carmustine—melanoma	0.000333	0.00291	CcSEcCtD
Tenofovir—Nervous system disorder—Docetaxel—melanoma	0.000333	0.0029	CcSEcCtD
Tenofovir—Dermatitis—Carmustine—melanoma	0.000333	0.0029	CcSEcCtD
Tenofovir—Headache—Carmustine—melanoma	0.000331	0.00289	CcSEcCtD
Tenofovir—Skin disorder—Docetaxel—melanoma	0.00033	0.00288	CcSEcCtD
Tenofovir—Vomiting—Temozolomide—melanoma	0.000325	0.00283	CcSEcCtD
Tenofovir—Anorexia—Docetaxel—melanoma	0.000324	0.00282	CcSEcCtD
Tenofovir—Rash—Temozolomide—melanoma	0.000322	0.00281	CcSEcCtD
Tenofovir—Dermatitis—Temozolomide—melanoma	0.000322	0.0028	CcSEcCtD
Tenofovir—Headache—Temozolomide—melanoma	0.00032	0.00279	CcSEcCtD
Tenofovir—Nausea—Carmustine—melanoma	0.000314	0.00274	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Docetaxel—melanoma	0.00031	0.0027	CcSEcCtD
Tenofovir—Insomnia—Docetaxel—melanoma	0.000307	0.00268	CcSEcCtD
Tenofovir—Nausea—Temozolomide—melanoma	0.000304	0.00264	CcSEcCtD
Tenofovir—Dyspnoea—Docetaxel—melanoma	0.000303	0.00264	CcSEcCtD
Tenofovir—Dyspepsia—Docetaxel—melanoma	0.000299	0.00261	CcSEcCtD
Tenofovir—Decreased appetite—Docetaxel—melanoma	0.000295	0.00257	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Docetaxel—melanoma	0.000293	0.00256	CcSEcCtD
Tenofovir—Fatigue—Docetaxel—melanoma	0.000293	0.00255	CcSEcCtD
Tenofovir—Pain—Docetaxel—melanoma	0.000291	0.00253	CcSEcCtD
Tenofovir—Gastrointestinal pain—Docetaxel—melanoma	0.000278	0.00242	CcSEcCtD
Tenofovir—Abdominal pain—Docetaxel—melanoma	0.000269	0.00234	CcSEcCtD
Tenofovir—Body temperature increased—Docetaxel—melanoma	0.000269	0.00234	CcSEcCtD
Tenofovir—Hypersensitivity—Docetaxel—melanoma	0.00025	0.00218	CcSEcCtD
Tenofovir—Asthenia—Docetaxel—melanoma	0.000244	0.00212	CcSEcCtD
Tenofovir—Pruritus—Docetaxel—melanoma	0.00024	0.0021	CcSEcCtD
Tenofovir—Adenosine triphosphate—ABCB1—melanoma	0.000238	0.036	CrCbGaD
Tenofovir—Diarrhoea—Docetaxel—melanoma	0.000233	0.00203	CcSEcCtD
Tenofovir—Dizziness—Docetaxel—melanoma	0.000225	0.00196	CcSEcCtD
Tenofovir—Vomiting—Docetaxel—melanoma	0.000216	0.00188	CcSEcCtD
Tenofovir—Rash—Docetaxel—melanoma	0.000214	0.00187	CcSEcCtD
Tenofovir—Dermatitis—Docetaxel—melanoma	0.000214	0.00187	CcSEcCtD
Tenofovir—Headache—Docetaxel—melanoma	0.000213	0.00186	CcSEcCtD
Tenofovir—Nausea—Docetaxel—melanoma	0.000202	0.00176	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000153	0.0011	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000153	0.0011	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000152	0.0011	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—GNAQ—melanoma	0.000152	0.00109	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP1B1—melanoma	0.000151	0.00108	CbGpPWpGaD
Tenofovir—NME2—Metabolism—VCAN—melanoma	0.000151	0.00108	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GPAM—melanoma	0.00015	0.00107	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000148	0.00106	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000147	0.00105	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ABCB1—melanoma	0.000147	0.00105	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000146	0.00105	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000144	0.00103	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—BSG—melanoma	0.000143	0.00102	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000142	0.00102	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SYK—melanoma	0.000142	0.00102	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000142	0.00102	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT3—melanoma	0.00014	0.001	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000139	0.001	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000139	0.001	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA5—melanoma	0.000138	0.000992	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—HGF—melanoma	0.000136	0.00098	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—FLNA—melanoma	0.000134	0.000963	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000133	0.000957	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000133	0.000953	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000132	0.000945	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00013	0.000937	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000129	0.000927	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000129	0.000925	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—AKR1B10—melanoma	0.000127	0.000914	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PLA2G6—melanoma	0.000127	0.000913	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ABCB1—melanoma	0.000127	0.000913	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP17A1—melanoma	0.000127	0.000913	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000126	0.000903	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—melanoma	0.000125	0.000897	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CLU—melanoma	0.000121	0.000871	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000121	0.000869	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GNA11—melanoma	0.00012	0.000862	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00012	0.000861	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RHOB—melanoma	0.000119	0.000852	CbGpPWpGaD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000118	0.000846	CbGpPWpGaD
Tenofovir—NME2—Metabolism—FASN—melanoma	0.000117	0.000844	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PRKCA—melanoma	0.000117	0.00084	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000117	0.00084	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—melanoma	0.000116	0.000835	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—HGF—melanoma	0.000116	0.000834	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ERCC2—melanoma	0.000116	0.000834	CbGpPWpGaD
Tenofovir—NME2—Metabolism—SLC5A5—melanoma	0.000116	0.00083	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—CSF2—melanoma	0.000115	0.000825	CbGpPWpGaD
Tenofovir—NME1—Metabolism—VCAN—melanoma	0.000114	0.00082	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GNAQ—melanoma	0.000112	0.000802	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CD44—melanoma	0.000112	0.000802	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—melanoma	0.000111	0.000796	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—ITGB3—melanoma	0.00011	0.000791	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PRKCA—melanoma	0.00011	0.000791	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—melanoma	0.000108	0.000773	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1B1—melanoma	0.000107	0.000769	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAC2—melanoma	0.000106	0.000763	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000106	0.00076	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFC—melanoma	0.000105	0.000751	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—RAC1—melanoma	0.000102	0.000733	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.88e-05	0.00071	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP17A1—melanoma	9.63e-05	0.000692	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SPARC—melanoma	9.18e-05	0.00066	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—F2R—melanoma	9.18e-05	0.00066	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ALB—melanoma	9.17e-05	0.000659	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CG—melanoma	9.16e-05	0.000658	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—NFKB1—melanoma	9.13e-05	0.000656	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GNA11—melanoma	9.1e-05	0.000654	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—FN1—melanoma	9.01e-05	0.000647	CbGpPWpGaD
Tenofovir—NME1—Metabolism—FASN—melanoma	8.9e-05	0.00064	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	8.85e-05	0.000636	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PPARG—melanoma	8.84e-05	0.000635	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ABCB1—melanoma	8.81e-05	0.000633	CbGpPWpGaD
Tenofovir—NME1—Metabolism—SLC5A5—melanoma	8.76e-05	0.000629	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—melanoma	8.62e-05	0.000619	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HSPA5—melanoma	8.59e-05	0.000617	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—CTNNB1—melanoma	8.54e-05	0.000613	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—EGF—melanoma	8.52e-05	0.000612	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	8.48e-05	0.000609	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GNAQ—melanoma	8.46e-05	0.000608	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CD44—melanoma	8.46e-05	0.000608	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	8.41e-05	0.000604	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—GAB2—melanoma	8.4e-05	0.000603	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—GNA11—melanoma	8.4e-05	0.000603	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PRKCA—melanoma	8.11e-05	0.000583	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1B1—melanoma	8.11e-05	0.000583	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CD—melanoma	8.06e-05	0.000579	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ERCC2—melanoma	8.04e-05	0.000578	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ALB—melanoma	7.95e-05	0.000571	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HDAC2—melanoma	7.9e-05	0.000567	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IGF1—melanoma	7.89e-05	0.000567	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CD44—melanoma	7.81e-05	0.000561	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—GNAQ—melanoma	7.81e-05	0.000561	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITGA4—melanoma	7.81e-05	0.000561	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNB1—melanoma	7.75e-05	0.000557	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	7.59e-05	0.000545	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—melanoma	7.58e-05	0.000544	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA1—melanoma	7.56e-05	0.000543	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—MDM2—melanoma	7.54e-05	0.000542	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—ALB—melanoma	7.48e-05	0.000537	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SYK—melanoma	7.34e-05	0.000527	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	7.3e-05	0.000524	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	7.27e-05	0.000522	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITGAV—melanoma	7.21e-05	0.000518	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT3—melanoma	7.21e-05	0.000518	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA2—melanoma	7.04e-05	0.000506	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CB—melanoma	7.02e-05	0.000504	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC5A5—melanoma	7e-05	0.000503	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—melanoma	6.96e-05	0.0005	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—melanoma	6.91e-05	0.000497	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	6.89e-05	0.000495	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	6.89e-05	0.000495	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	6.85e-05	0.000492	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	6.8e-05	0.000489	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	6.74e-05	0.000484	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ABCB1—melanoma	6.68e-05	0.00048	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP17A1—melanoma	6.67e-05	0.000479	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—melanoma	6.61e-05	0.000475	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	6.58e-05	0.000473	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITGB1—melanoma	6.54e-05	0.00047	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	6.36e-05	0.000457	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CG—melanoma	6.35e-05	0.000456	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	6.31e-05	0.000453	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PRKCA—melanoma	6.15e-05	0.000441	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PPARG—melanoma	6.13e-05	0.00044	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ERCC2—melanoma	6.1e-05	0.000438	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	6.09e-05	0.000438	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—melanoma	6.07e-05	0.000436	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—melanoma	6.07e-05	0.000436	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HGF—melanoma	5.99e-05	0.00043	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CSF2—melanoma	5.92e-05	0.000425	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC5A5—melanoma	5.9e-05	0.000424	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	5.73e-05	0.000411	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	5.72e-05	0.000411	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITGB3—melanoma	5.67e-05	0.000408	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PRKCA—melanoma	5.67e-05	0.000408	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	5.66e-05	0.000406	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1B1—melanoma	5.62e-05	0.000404	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CD—melanoma	5.58e-05	0.000401	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	5.57e-05	0.0004	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	5.54e-05	0.000398	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALB—melanoma	5.51e-05	0.000396	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCB1—melanoma	5.34e-05	0.000383	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	5.27e-05	0.000379	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAC1—melanoma	5.26e-05	0.000378	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—melanoma	5.16e-05	0.00037	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	5.16e-05	0.00037	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	5.16e-05	0.00037	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	5.16e-05	0.00037	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	5.1e-05	0.000366	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MMP1—melanoma	5.09e-05	0.000366	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CDK2—melanoma	5e-05	0.000359	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	4.91e-05	0.000353	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	4.91e-05	0.000353	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—melanoma	4.88e-05	0.00035	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	4.87e-05	0.00035	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CB—melanoma	4.87e-05	0.00035	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—melanoma	4.82e-05	0.000346	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CG—melanoma	4.81e-05	0.000346	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPARG—melanoma	4.65e-05	0.000334	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	4.65e-05	0.000334	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—FN1—melanoma	4.64e-05	0.000334	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK1—melanoma	4.64e-05	0.000333	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS2—melanoma	4.59e-05	0.00033	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	4.5e-05	0.000323	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CG—melanoma	4.44e-05	0.000319	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EGF—melanoma	4.39e-05	0.000316	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—melanoma	4.28e-05	0.000307	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	4.25e-05	0.000305	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CD—melanoma	4.23e-05	0.000304	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—melanoma	4.21e-05	0.000302	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALB—melanoma	4.18e-05	0.0003	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	4.14e-05	0.000297	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF1—melanoma	4.07e-05	0.000292	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—melanoma	4.03e-05	0.000289	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	3.98e-05	0.000286	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CD—melanoma	3.91e-05	0.000281	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ALB—melanoma	3.86e-05	0.000277	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACER3—melanoma	3.75e-05	0.000269	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CB—melanoma	3.69e-05	0.000265	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—melanoma	3.66e-05	0.000263	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—melanoma	3.5e-05	0.000251	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	3.48e-05	0.00025	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UGT2B10—melanoma	3.43e-05	0.000246	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CB—melanoma	3.41e-05	0.000245	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.38e-05	0.000243	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ALB—melanoma	3.34e-05	0.00024	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—melanoma	3.29e-05	0.000236	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—melanoma	3.19e-05	0.000229	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HS3ST5—melanoma	3.18e-05	0.000229	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—melanoma	3.13e-05	0.000225	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—melanoma	2.97e-05	0.000213	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	2.91e-05	0.000209	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	2.82e-05	0.000202	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—melanoma	2.66e-05	0.000191	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NRAS—melanoma	2.63e-05	0.000189	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.56e-05	0.000184	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK3—melanoma	2.51e-05	0.000181	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—melanoma	2.42e-05	0.000174	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PLCB4—melanoma	2.41e-05	0.000173	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK1—melanoma	2.39e-05	0.000172	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.37e-05	0.00017	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC6A11—melanoma	2.27e-05	0.000163	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIP4K2A—melanoma	2.27e-05	0.000163	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—melanoma	2.26e-05	0.000162	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—melanoma	2.25e-05	0.000162	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTAP—melanoma	2.21e-05	0.000159	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.16e-05	0.000155	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—melanoma	2.08e-05	0.000149	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—melanoma	2.01e-05	0.000144	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PHGDH—melanoma	1.97e-05	0.000141	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—LUM—melanoma	1.97e-05	0.000141	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPSE—melanoma	1.93e-05	0.000139	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—melanoma	1.92e-05	0.000138	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CUBN—melanoma	1.89e-05	0.000136	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—melanoma	1.84e-05	0.000132	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SDHD—melanoma	1.83e-05	0.000131	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—BSG—melanoma	1.83e-05	0.000131	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CSPG4—melanoma	1.83e-05	0.000131	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPAM—melanoma	1.77e-05	0.000127	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—melanoma	1.7e-05	0.000122	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PLA2G6—melanoma	1.51e-05	0.000108	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—VCAN—melanoma	1.35e-05	9.72e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.28e-05	9.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.24e-05	8.88e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP17A1—melanoma	1.14e-05	8.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.13e-05	8.09e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.11e-05	7.98e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GNA11—melanoma	1.08e-05	7.74e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FASN—melanoma	1.05e-05	7.58e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC5A5—melanoma	1.04e-05	7.45e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CD44—melanoma	1e-05	7.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GNAQ—melanoma	1e-05	7.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.81e-06	7.05e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.72e-06	6.98e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1B1—melanoma	9.61e-06	6.9e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.48e-06	6.09e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCB1—melanoma	7.91e-06	5.68e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PRKCA—melanoma	7.28e-06	5.23e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ERCC2—melanoma	7.22e-06	5.19e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.98e-06	4.3e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CG—melanoma	5.7e-06	4.1e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARG—melanoma	5.5e-06	3.95e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CD—melanoma	5.01e-06	3.6e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALB—melanoma	4.95e-06	3.56e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CB—melanoma	4.37e-06	3.14e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—melanoma	4.33e-06	3.11e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—melanoma	3.78e-06	2.71e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—melanoma	2.66e-06	1.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—melanoma	2.18e-06	1.56e-05	CbGpPWpGaD
